Montelukast Sodium
Rank #186 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$81.3M
Total Cost
5,086,706
Total Claims
$81.3M
Total Cost
84,070
Prescribers
$16
Cost per Claim
1,282,336
Beneficiaries
11,141,054
30-Day Fills
$967
Avg Cost/Provider
61
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$81.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $81.3M total
🔎 Data Overview
At $16.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Montelukast Sodium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 8,261 | $72K |
| 2 | Abigail Harada | Allergy/ Immunology | Honolulu, HI | 707 | $38K |
| 3 | Theodossis Zacharis | Pulmonary Disease | New Smyrna Beach, FL | 1,669 | $37K |
| 4 | Stuart Sugihara | Pulmonary Disease | Honolulu, HI | 680 | $35K |
| 5 | Najmuddin Karimjee | Internal Medicine | Houston, TX | 1,696 | $33K |
| 6 | Phillip Haddad | Pulmonary Disease | Shawnee, OK | 1,605 | $33K |
| 7 | Jahaira Serrano Dominguez | Pulmonary Disease | Arecibo, PR | 4,575 | $33K |
| 8 | Isabel Mendoza | Family Practice | Darlington, SC | 41 | $32K |
| 9 | Jason Karp | Pulmonary Disease | Lake Success, NY | 1,679 | $30K |
| 10 | Mitchell Davis | Family Practice | Ada, OK | 297 | $29K |
| 11 | Mohammad Chaudhry | Internal Medicine | Union City, NJ | 1,511 | $27K |
| 12 | Bilal Khan | Allergy/ Immunology | Topeka, KS | 1,255 | $27K |
| 13 | Matthew Dykema | Family Practice | Hilo, HI | 557 | $27K |
| 14 | Vishal Sawhney | Pulmonary Disease | Canton, OH | 1,671 | $26K |
| 15 | Carol Demond | Nurse Practitioner | Miami, OK | 318 | $25K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
| 184 | Mifepristone (Korlym) | $83.3M | 2,397 |
| 185 | Insulin Nph Hum/Reg Insulin Hm (Humulin 70-30) | $82.3M | 177,501 |
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
| 187 | Certolizumab Pegol (Cimzia) | $79.9M | 11,784 |
| 188 | Celecoxib (Celecoxib) | $77.7M | 1,938,505 |
| 189 | Sod Phenylbutyrat/Taurursodiol (Relyvrio) | $77.0M | 6,152 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology